Design and Synthesis of Aza-β-Carboline Analogs and their Antibacterial Evaluation
作者:Guoxing Xu、Qi Wei、Fuhang Song、Huanqin Dai、Lihua Deng、Xiaoping Zhou、Lixin Zhang、Qun Dang、Xu Bai
DOI:10.1007/s11094-021-02429-6
日期:——
Bacterial drug resistance has become a growing problem worldwide due to the excessive use of antibiotics in recent decades. Two small focused libraries of 5H-pyrimido[5,4-b]indole-4-carboxamides and 5H-pyrimido-[5,4-b]indole-4-ketones were designed as eudistomin Y3 and 1-acetyl-β-carboline (1-ABC) analogs and prepared via application of Inverse Electron-Demand Diels-Alder (IEDDA) reaction of 1,3,5-triazines and 3-aminoindoles. Compounds 2a and 2b were discovered to have activity against Mycobacterium bovis BCG with Minimum Inhibitory Concentration (MICs) values of 25 and 50 μg/mL respectively while compound 2e was against all three strains of Candida albicans tested with MIC values of 50 μg/mL. Moreover, compound 2e demonstrated synergistic antibacterial activity with fluconazol, which suggested that future drug candidates from this class of compounds could be used in combination with existing drugs to treat C. albicans infections.
由于近几十年来抗生素的过度使用,细菌耐药性已成为一个日益严重的全球性问题。通过应用 1,3,5-三嗪和 3-氨基吲哚的逆电子需求 Diels-Alder(IEDDA)反应,设计了两个 5H-嘧啶并[5,4-b]吲哚-4-甲酰胺和 5H-嘧啶并[5,4-b]吲哚-4-酮的小型重点文库,作为 eudistomin Y3 和 1-乙酰基-β-咔啉(1-ABC)类似物。研究发现,化合物 2a 和 2b 对牛分枝杆菌卡介苗具有活性,最低抑菌浓度(MICs)分别为 25 和 50 μg/mL,而化合物 2e 对所测试的三种白色念珠菌菌株均具有活性,最低抑菌浓度为 50 μg/mL。此外,化合物 2e 与氟康唑具有协同抗菌活性,这表明该类化合物的未来候选药物可与现有药物联合使用,治疗白色念珠菌感染。